Pediatric Innovation Isn’t a Small-Market Problem, It’s an Incentive Problem
Investing in pediatric care is not simply a moral imperative. It is one of the most practical long-term investments the healthcare system can make.
Investing in pediatric care is not simply a moral imperative. It is one of the most practical long-term investments the healthcare system can make.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
As a country, we have developed treatments capable of improving the quality of life and preventing long-term damage for children with rheumatic conditions, yet many children cannot obtain them when they need them most. This needs to change.
What happened was not just a cybersecurity failure, it was an infrastructure failure.
When the healthcare system defaults to uncertainty, people delay care because it feels safer for their wallets. In some cases, people wait too long, leaving an ER visit as the path of least resistance.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
Gaps in reimbursement oversight and recovery will only widen, unless plans modernize how they detect, investigate, and recoup improper payments.
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is that not only is this terrible for patient health, it can be more costly in the end.
Tolerance for this abrasion is gone. It wastes time, drains staff capacity, drives up costs, and affects the patient experience.
A new report from Forrester offers a score card assessing health tech vendors on customer experience for healthcare organizations considering adopting them.
The between a code that satisfies a payer and the information a physician needs to treat a person, is what nearly every healthcare AI tool is racing past. As we push these systems toward precision medicine and genomics, that gap stops being an annoyance and becomes a patient safety issue.
A new whitepaper by League highlights examples from collaborations with Baptist Health.